Lafutoga Home (Lafutidine)

Adult dose

1. Short-term treatment of gastric ulcers: The usual dose is 10mg of lafutidine per dose, administered orally 2 times daily in the morning and at bedtime. Clinical trials of up to 8 weeks showed that most ulcers healed within 8 weeks, although healing time may occasionally vary from patient to patient. 2. Short-term treatment of duodenal ulcers: The usual dose is 10mg of lafutidine per dose, administered orally 2 times daily in the morning and at bedtime. Clinical trials of up to 6 weeks showed that most ulcers healed within 6 weeks, although healing time may occasionally vary from patient to patient. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose is 10mg of lafutidine once daily, administered orally at bedtime. Clinical trials of up to 2 weeks showed that most lesions healed within 2 weeks, although healing time may occasionally vary from patient to patient. 4. Combination therapy with antibiotics in patients with peptic ulcer disease infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg 2 times daily for 7 days or 14 days. 5. Premedication for anesthesia: The usual dose is 10mg of lafutidine per dose, administered orally 2 times (at bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer 10mg of lafutidine per dose orally 2 times daily.

This medication should not be used by patients allergic to its components. This medication contains lactose, so patients with a deficiency of lactase or genetic problems that prevent lactose digestion should not take it. Patients with a history of drug allergies, those with liver or kidney function problems, patients undergoing dialysis, and elderly patients should be particularly cautious when using this medication. Severe allergic reactions such as anaphylaxis may occur during treatment, so if symptoms like paleness, low blood pressure, or difficulty breathing occur, the medication should be discontinued immediately and medical attention sought. Liver function abnormalities or jaundice may develop, so regular liver function tests are necessary, and if any abnormalities arise, the medication should be stopped. Symptoms such as agranulocytosis or thrombocytopenia resulting in reduced blood cell counts may occur, so if sore throat, fatigue, or fever appear, medical advice should be sought immediately. Rarely, serious side effects such as skin rash, convulsions, nephritis, and heart issues have been reported, so if these symptoms occur, immediate medical attention is required. Gastrointestinal symptoms such as constipation, diarrhea, vomiting, and loss of appetite may occur, along with central nervous system symptoms such as headache, drowsiness, insomnia, and dizziness. Liver enzyme levels may rise, kidney function anomalies, and blood test result changes may occur, so regular testing is needed. This medication is used to treat gastric ulcers or gastroesophageal reflux disease, and if symptoms do not improve during treatment or if malignancy is suspected, further examination is required. Elderly patients may have reduced physiological functions, so dosage and administration intervals should be adjusted and used cautiously. Dialysis patients may have increased drug levels in the blood, so they should start with a low dose and adjust gradually. Pregnant women should only be given this medication if the benefits outweigh the risks, based on a doctor’s judgement, and nursing mothers should avoid taking it as it may be excreted in breast milk. The safety of this medication in children has not been established, so it is advisable not to use it in pediatric patients. The medication should be stored out of reach of children, and it should be kept in its original container; transferring it to another container may risk misuse or degradation of quality.

• Shock
• symptoms of anaphylaxis
• facial pallor
• hypotension
• generalized rash
• dyspnea
• liver dysfunction
• jaundice
• agranulocytosis
• pharyngitis

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is recommended to keep the storage temperature between 1°C and 30°C.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle